Skip to main content
Fig. 5 | Experimental Hematology & Oncology

Fig. 5

From: Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information

Fig. 5

Integrated analysis of EHR data using AI and introduction of its application to diagnosis and treatment. A Figure showing a series of processes to predict the risk of preventable ACU after chemotherapy initiation using the machine learning algorithm trained on comprehensive EHR data, modified from Ref. [151]. Nine machine learning models were developed, validated, and compared to predict ACU at 3, 6, and 12 months after chemotherapy initiation in patients presenting to an oncology clinic affiliated with a large academic cancer center. Patient-reported outcomes were also incorporated to assess the impact of these data in predicting the risk of preventable ACU. B Schematic of a lung cancer prognostic study using a clinical cohort constructed from EHR data, modified from Ref. [158]. Initially, data are obtained from the EHR and lung cancer diagnosis codes are used as filters. After creating a data mart containing structured data and narrative notes, the structured data are queried and the narrative notes are processed using NLP tools. A phenotyping algorithm has been developed using a combination of structured data and narrative notes to extract variables of interest. The performance of the phenotyping algorithm is compared to a random sample of patients selected for EHR review. The performance of the phenotyping algorithm is compared to a random sample of patients selected for EHR review. The accuracy of the extracted variables is compared to the EHR reviewed sample and the Boston Lung Cancer Study cohort data

Back to article page